Recent advances in nanotherapeutics for epilepsy and neurodegenerative diseases
Open Access
- 15 July 2023
- journal article
- review article
- Published by IP Innovative Publication Pvt Ltd in Journal of Pharmaceutical and Biological Sciences
- Vol. 11 (1) , 30-34
Abstract
This review focuses on the potential of nanotherapeutics in the diagnosis and treatment of neuronal abnormal conditions particularly epilepsy, alzheimer's disease (AD), and Parkinson's disease (PD). The advancements in nanotechnology have paved the way for the development of nanocarrier systems that can target the underlying pathogenesis of these diseases. The study aimed to explore the efficacy of nanosystems in treating epilepsy, AD, and PD by analyzing relevant articles from databases such as Medline, PubMed and the national library of medicine. The review discusses the targeted delivery of active therapeutics to the central nervous system, with a focus on modulating neuronal and endothelial cell activity. It highlights various nanotherapeutic approaches, including pH-responsive nanomaterial-based therapeutics, nano-bioelectronic-implantable transient electronic devices, and electro-responsive nanosystems for the treatment of epilepsy. Additionally, the efficacy of nanodrug delivery systems loaded with curcumin, monoclonal anti-tau antibody-coated gold nanoparticles, Polyethylene Glycolpolylactide-Polyglycolide (PEG-PLGA) nanoparticles loaded with lactoferrin, dopamine-conjugated Albumin/PLGA nanosystems, and curcumin-loaded T807/RPCNP nanoparticles against neurodegeneration is discussed. The findings of this review provide valuable insights into the implications and challenges of nanotherapeutics in the field of neurological diseases. Neurologists and clinicians can benefit from this knowledge to better understand the potential applications of nanotherapeutics in the diagnosis and treatment of these conditions.Keywords
This publication has 32 references indexed in Scilit:
- Challenges and strategies in anti-cancer nanomedicine development: An industry perspectiveAdvanced Drug Delivery Reviews, 2017
- Nanomedicine applied to translational oncology: A future perspective on cancer treatmentNanomedicine: Nanotechnology, Biology and Medicine, 2016
- Specific self-monitoring of metal-associated amyloid-β peptide disaggregation by a fluorescent chelatorChemical Communications, 2015
- Epilepsy: new advancesThe Lancet, 2015
- Visible-light-induced synthesis of pH-responsive composite hydrogels for controlled delivery of the anticonvulsant drug pregabalinActa Biomaterialia, 2015
- Inhibition of Amyloid Fibril Growth and Dissolution of Amyloid Fibrils by Curcumin–Gold NanoparticlesChemistry – A European Journal, 2014
- Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: The example of Alzheimer's diseaseAnnales Pharmaceutiques Françaises, 2013
- Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Nanomedicine—Challenge and PerspectivesAngewandte Chemie International Edition, 2009